Related references
Note: Only part of the references are listed.Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections
Mohammed A. Sadat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
Xuesen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Current progress in antiviral strategies
Zhiyong Lou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
Kai Lin et al.
ANTIVIRAL RESEARCH (2013)
An iminosugar with potent inhibition of dengue virus infection in vivo
Stuart T. Perry et al.
ANTIVIRAL RESEARCH (2013)
Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells
Kazuya I. P. J. Hidari et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections
Yanming Du et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Glycoprotein misfolding in the endoplasmic reticulum: identification of released oligosaccharides reveals a second ER-associated degradation pathway for Golgi-retrieved proteins
Dominic S. Alonzi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Pathogenesis of the Viral Hemorrhagic Fevers
Slobodan Paessler et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Liposome-Mediated Delivery of Iminosugars Enhances Efficacy against Dengue Virus In Vivo
Joanna L. Miller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2012)
Respiratory viral infections: knowledge based therapeutics
Tracy Hussell et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
New respiratory viral infections
Tuomas Jartti et al.
CURRENT OPINION IN PULMONARY MEDICINE (2012)
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens
Victoria A. Meliopoulos et al.
FASEB JOURNAL (2012)
Design, Synthesis, and Biological Evaluation of N-Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
Wenquan Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus
Masaya Fukushi et al.
JOURNAL OF VIROLOGY (2012)
New horizons for antiviral drug discovery from virus-host protein interaction networks
Benoit de Chassey et al.
CURRENT OPINION IN VIROLOGY (2012)
Inhibitors of Endoplasmic Reticulum α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release
Xiaowang Qu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model
Abhay P. S. Rathore et al.
ANTIVIRAL RESEARCH (2011)
Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
Han-Xin Lin et al.
VIRUS RESEARCH (2011)
Cellular Networks Involved in the Influenza Virus Life Cycle
Tokiko Watanabe et al.
CELL HOST & MICROBE (2010)
Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections
Dong Jiang et al.
JOURNAL OF VIROLOGY (2010)
Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein
Gayle Ritchie et al.
VIROLOGY (2010)
Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses
Jinhong Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
Kailang Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction
Han-Xin Lin et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus
Dong Jiang et al.
JOURNAL OF VIROLOGY (2008)
Treatment of hepatitis B virus-infected cells with α-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity
Catalin Lazar et al.
ANTIVIRAL RESEARCH (2007)
Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo
Kazuaki Inoue et al.
HEPATOLOGY (2007)
Antiviral effect of α-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles
C Chapel et al.
JOURNAL OF GENERAL VIROLOGY (2006)
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells
IC Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme
E Simsek et al.
JOURNAL OF VIROLOGY (2005)
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo
K Whitby et al.
JOURNAL OF VIROLOGY (2005)
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
H Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Influenza virus entry and infection require host cell N-linked glycoprotein
VC Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
3-deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice
M Bray et al.
ANTIVIRAL RESEARCH (2002)
Antiviral effects of an iminosugar derivative on flavivirus infections
SF Wu et al.
JOURNAL OF VIROLOGY (2002)
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
M Bray et al.
ANTIVIRAL RESEARCH (2000)
Share Paper
